Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

55.32 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 145
Open 55.32
Bid (Size) 54.36 (100)
Ask (Size) 55.99 (400)
Prev. Close 55.32
Today's Range 55.32 - 55.32
52wk Range 50.76 - 73.51
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Cash-Producing Stocks with Promising Prospects
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum. 
Via StockStory

Performance

YTD
-16.8%
-16.8%
1 Month
+5.5%
+5.5%
3 Month
-5.1%
-5.1%
6 Month
-5.8%
-5.8%
1 Year
-16.3%
-16.3%

More News

Read More
News headline image
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday ↗
Via The Motley Fool
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Via StockStory
Topics Earnings Economy Government
News headline image
Biomarin Pharmaceutical Analysts Cut Their Forecasts After Downbeat Earnings ↗
Via Benzinga
News headline image
BMRN Q3 Deep Dive: Product Expansion and Portfolio Shifts Define Outlook
Via StockStory
News headline image
BioMarin (BMRN) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Reports Mixed Q3 2025 Results with Revenue Growth but Earnings Miss ↗
Via Chartmill
Topics Earnings
News headline image
BioMarin Pharmaceutical (NASDAQ:BMRN) Posts Q3 Sales In Line With Estimates
Via StockStory
News headline image
Earnings Scheduled For October 27, 2025 ↗
Via Benzinga
News headline image
BioMarin Pharmaceutical (BMRN) Reports Q3: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
News headline image
What to Expect from Biomarin Pharmaceutical's Earnings ↗
Via Benzinga
News headline image
3 of Wall Street’s Favorite Stocks to Target This Week
Via StockStory
News headline image
1 Healthcare Stock Worth Investigating and 2 We Question
Via StockStory
Topics Stocks
News headline image
1 Mid-Cap Stock to Research Further and 2 That Underwhelm
Via StockStory
News headline image
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government World Trade
News headline image
Is BioMarin Pharmaceutical Inc Gaining or Losing Market Support? ↗
Via Benzinga
News headline image
6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know ↗
Via Benzinga
News headline image
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
Peering Into BioMarin Pharmaceutical's Recent Short Interest ↗
Via Benzinga
News headline image
2 Profitable Stocks on Our Watchlist and 1 We Turn Down
Via StockStory
News headline image
Reflecting On Therapeutics Stocks’ Q2 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 55.32
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 11/12/25 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.14B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.